98 related articles for article (PubMed ID: 27073685)
1. Levels of serum fibronectin as a biomarker in gastric cancer patients: Correlation with clinical diagnosis and outcome.
Tas F; Bilgin E; Karabulut S; Tastekin D; Duranyildiz D
Mol Clin Oncol; 2016 Apr; 4(4):655-659. PubMed ID: 27073685
[TBL] [Abstract][Full Text] [Related]
2. Circulating annexin A2 as a biomarker in gastric cancer patients: correlation with clinical variables.
Tas F; Tilgen Yasasever C; Karabulut S; Tastekin D; Duranyildiz D
Biomed Pharmacother; 2015 Feb; 69():237-41. PubMed ID: 25661364
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of serum protease-activated receptor-1 levels in gastric cancer patients.
Tas F; Karabulut S; Tastekin D; Duranyildiz D
Biomed Rep; 2016 Apr; 4(4):489-492. PubMed ID: 27073639
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of serum interleukin-18 (IL-18) levels in patients with gastric cancer.
Tas F; Tilgen Yasasever C; Karabulut S; Tastekin D; Duranyildiz D
Biomed Pharmacother; 2015 Mar; 70():19-23. PubMed ID: 25776473
[TBL] [Abstract][Full Text] [Related]
5. Serum transforming growth factor-beta1 levels may have predictive and prognostic roles in patients with gastric cancer.
Tas F; Yasasever CT; Karabulut S; Tastekin D; Duranyildiz D
Tumour Biol; 2015 Mar; 36(3):2097-103. PubMed ID: 25391430
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of serum fibronectin and vitronectin levels in melanoma patients.
Tas F; Karabulut S; Bilgin E; Tastekin D; Duranyildiz D
Melanoma Res; 2014 Oct; 24(5):475-9. PubMed ID: 24999757
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of serum caveolin-1 levels in melanoma patients.
Tas F; Karabulut S; Tilgen Yasasever C; Duranyildiz D
Int J Dermatol; 2016 May; 55(5):558-62. PubMed ID: 26084616
[TBL] [Abstract][Full Text] [Related]
8. Elevated circulating monocyte chemoattractant protein 1 (MCP-1/CCL-2) level may be an unfavorable predictive factor to platinum- and taxane-based combination chemotherapy in patients with gastric cancer.
Tas F; Karabulut S; Serilmez M; Karabulut M; Duranyildiz D
Cancer Chemother Pharmacol; 2016 Jan; 77(1):127-31. PubMed ID: 26499899
[TBL] [Abstract][Full Text] [Related]
9. Clinical Significance of Serum Galectin-3 Levels in Gastric Cancer Patients.
Tas F; Bilgin E; Tastekin D; Erturk K; Duranyildiz D
J Gastrointest Cancer; 2016 Jun; 47(2):182-6. PubMed ID: 27038444
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of serum epidermal growth factor receptor (EGFR) levels in patients with breast cancer.
Tas F; Bilgin E; Karabulut S; Duranyildiz D
Cytokine; 2015 Jan; 71(1):66-70. PubMed ID: 25259789
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of serum claudin-1 levels in melanoma patients.
Tas F; Bilgin E; Erturk K; Duranyildiz D
Melanoma Res; 2016 Aug; 26(4):377-81. PubMed ID: 26886788
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of serum Protease-Activated Receptor-1 (PAR-1) levels in patients with cutaneous melanoma.
Tas F; Bilgin E; Karabulut S; Erturk K; Duranyildiz D
BBA Clin; 2016 Jun; 5():166-9. PubMed ID: 27141440
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of serum leptin level in patients with gastric cancer.
Tas F; Karabulut S; Erturk K; Duranyildiz D
Eur Cytokine Netw; 2018 Jun; 29(2):52-58. PubMed ID: 30078770
[TBL] [Abstract][Full Text] [Related]
14. Serum TIMP-1 in gastric cancer patients: a potential prognostic biomarker.
Wang CS; Wu TL; Tsao KC; Sun CF
Ann Clin Lab Sci; 2006; 36(1):23-30. PubMed ID: 16501233
[TBL] [Abstract][Full Text] [Related]
15. Serum neural precursor cell-expressed, developmentally down regulated 9 (NEDD9) level may have a prognostic role in patients with gastric cancer.
Karabulut M; Alis H; Afsar CU; Karabulut S; Kocatas A; Oguz H; Aykan NF
Biomed Pharmacother; 2015 Jul; 73():140-6. PubMed ID: 26211595
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of serum laminin levels in patients with lung cancer.
Tas F; Bilgin E; Tastekin D; Erturk K; Duranyildiz D
Biomed Rep; 2016 Apr; 4(4):485-488. PubMed ID: 27073638
[TBL] [Abstract][Full Text] [Related]
17. Increased serum level of epidermal growth factor receptor (EGFR) is associated with poor progression-free survival in patients with epithelial ovarian cancer.
Tas F; Karabulut S; Serilmez M; Ciftci R; Duranyildiz D
Cancer Chemother Pharmacol; 2014 Mar; 73(3):631-7. PubMed ID: 24477605
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of serum caveolin-1 levels in gastric cancer patients.
Tas F; Karabulut S; Erturk K; Duranyildiz D
Exp Oncol; 2018 Dec; 40(4):323-327. PubMed ID: 30593761
[TBL] [Abstract][Full Text] [Related]
19. Serum activated leukocyte cell adhesion molecule and intercellular adhesion molecule-1 in patients with gastric cancer: Can they be used as biomarkers?
Erturk K; Tastekin D; Bilgin E; Serilmez M; Bozbey HU; Sakar B
Biomed Pharmacother; 2016 Feb; 77():86-91. PubMed ID: 26796270
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of serum claudin-1 and claudin-7 levels in patients with colorectal cancer.
Karabulut M; Alis H; Bas K; Karabulut S; Afsar CU; Oguz H; Gunaldi M; Akarsu C; Kones O; Aykan NF
Mol Clin Oncol; 2015 Nov; 3(6):1255-1267. PubMed ID: 26807230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
